Status:

COMPLETED

Multi-omics Mechanisms of Lifestyle Intervention in Regulating Blood Glucose

Lead Sponsor:

Shanghai 6th People's Hospital

Conditions:

Diabetes

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

The mechanisms by which lifestyle interventions regulate blood glucose remain incompletely understood. Traditional research has predominantly focused on single targets or pathways, making it difficult...

Eligibility Criteria

Inclusion

  • Aged 18-70 years

Exclusion

  • Severe chronic diabetic complications or recent acute diabetic complications
  • Type 1 diabetes mellitus
  • Early-onset diabetes
  • Patients currently using insulin therapy
  • Recent severe hypoglycemic episodes
  • Secondary obesity
  • Pregnancy, severe hepatic/renal diseases, thyroid disorders, acute infections, psychiatric disorders, or other conditions that may interfere with study outcomes

Key Trial Info

Start Date :

August 31 2025

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 30 2025

Estimated Enrollment :

61 Patients enrolled

Trial Details

Trial ID

NCT07146308

Start Date

August 31 2025

End Date

October 30 2025

Last Update

November 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shanghai Sixth People's Hospital

Shanghai, Shanghai Municipality, China, 200233